JPMorgan lowered the firm’s price target on Merit Medical (MMSI) to $77 from $95 and keeps an Overweight rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MMSI:
- Merit Medical price target lowered to $90 from $101 at Needham
- Merit Medical price target lowered to $83 from $101 at Raymond James
- Merit Medical price target lowered to $80 from $100 at BofA
- Analyst Reiterates Buy on Merit Medical Systems as Strong Q1 Results and Cash Generation Offset Growth Deceleration, Trims Price Target to $90 on Sector Multiple Compression
- Steed Maintains Hold on Balanced Risk-Reward, Cutting Price Target to $80 Despite Solid Q1 Beat and Slight Guidance Raise